Literature DB >> 21115049

Swine adipose stromal cells loaded with recombinant bovine herpesvirus 4 virions expressing a foreign antigen induce potent humoral immune responses in pigs.

Gaetano Donofrio1, Simone Taddei, Valentina Franceschi, Antonio Capocefalo, Sandro Cavirani, Nicola Martinelli, Simone Ottonello, Maura Ferrari.   

Abstract

Increasingly effective vaccination strategies are needed to counteract the high incidence of contagious diseases associated with intensive swine breeding. Recombinant viral vaccines are a promising new avenue in this direction. Key features of viral vectors suitable for immunoprophylaxis are safety, ease of manipulation and the ability to replicate in a variety of hosts. Most of the above requirements are met by bovine herpesvirus 4 (BoHV-4), a non-pathogenic dsDNA virus capable of infecting a broad range of cell types in vitro. Here we report the results of an exploratory study using an engineered BoHV-4 virus (eBoHV-4) expressing two unrelated glycoprotein antigens from bovine viral diarrhea virus (BVDV) and bovine herpesvirus 1 (BoHV-1), to assess the potential of recombinant BoHV-4 as a self-adjuvanted immunogen in pigs. Free eBoHV-4 virions and virions preloaded into homologous swine adipose-derived stromal cells (SADSC) were tested. Neither virus formulation elicited neutralizing anti-BoHV-4 antibodies, nor any disease symptom, yet both induced specific immune responses against the heterologous antigens. However, a much earlier (18 vs 28 days post-infection) and more robust neutralizing response against BVDV and BoHV-1 viruses was elicited by eBoHV-4-preinfected SADSCs compared to free virions. The data validate BoHV-4 as a safe and effective heterologous antigen carrier/producer and identify SADSCs as helpful tools for the formulation of increasingly efficacious recombinant immunogens for pig vaccination. Copyright Â
© 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21115049     DOI: 10.1016/j.vaccine.2010.11.048

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  12 in total

1.  In vivo image analysis of BoHV-4-based vector in mice.

Authors:  Valentina Franceschi; Fabio Franco Stellari; Carlo Mangia; Sarah Jacca; Sophia Lavrentiadou; Sandro Cavirani; Mathias Heikenwalder; Gaetano Donofrio
Journal:  PLoS One       Date:  2014-04-21       Impact factor: 3.240

2.  Generation and characterization of the first immortalized alpaca cell line suitable for diagnostic and immunization studies.

Authors:  Valentina Franceschi; Sarah Jacca; Elena L Sassu; Fabio F Stellari; Vicky L van Santen; Gaetano Donofrio
Journal:  PLoS One       Date:  2014-08-20       Impact factor: 3.240

3.  BoHV-4-based vector delivering Ebola virus surface glycoprotein.

Authors:  Alfonso Rosamilia; Sarah Jacca; Giulia Tebaldi; Silvia Tiberti; Valentina Franceschi; Francesca Macchi; Sandro Cavirani; Gary Kobinger; Donald P Knowles; Gaetano Donofrio
Journal:  J Transl Med       Date:  2016-11-24       Impact factor: 5.531

4.  Assessment and optimization of Theileria parva sporozoite full-length p67 antigen expression in mammalian cells.

Authors:  Giulia Tebaldi; Laura B Williams; Andrea E Verna; Francesca Macchi; Valentina Franceschi; Lindsay M Fry; Donald P Knowles; Gaetano Donofrio
Journal:  PLoS Negl Trop Dis       Date:  2017-08-11

5.  Clinical protection of goats against CpHV-1 induced genital disease with a BoHV-4-based vector expressing CpHV-1 gD.

Authors:  Gaetano Donofrio; Valentina Franceschi; Angela Lovero; Antonio Capocefalo; Michele Camero; Michele Losurdo; Sandro Cavirani; Mariarosaria Marinaro; Erika Grandolfo; Canio Buonavoglia; Maria Tempesta
Journal:  PLoS One       Date:  2013-01-03       Impact factor: 3.240

6.  BoHV-4 immediate early 1 gene is a dispensable gene and its product is not a bone marrow stromal cell antigen 2 counteracting factor.

Authors:  Valentina Franceschi; Antonio Capocefalo; Sarah Jacca; Alfonso Rosamilia; Sandro Cavirani; Fengwen Xu; Wentao Qiao; Gaetano Donofrio
Journal:  BMC Vet Res       Date:  2015-08-27       Impact factor: 2.741

7.  BoHV-4-Based Vector Single Heterologous Antigen Delivery Protects STAT1(-/-) Mice from Monkeypoxvirus Lethal Challenge.

Authors:  Valentina Franceschi; Scott Parker; Sarah Jacca; Ryan W Crump; Konstantin Doronin; Edguardo Hembrador; Daniela Pompilio; Giulia Tebaldi; Ryan D Estep; Scott W Wong; Mark R Buller; Gaetano Donofrio
Journal:  PLoS Negl Trop Dis       Date:  2015-06-18

8.  Bovine herpesvirus 4-based vector delivering a hybrid rat/human HER-2 oncoantigen efficiently protects mice from autochthonous Her-2+ mammary cancer.

Authors:  Sarah Jacca; Valeria Rolih; Elena Quaglino; Valentina Franceschi; Giulia Tebaldi; Elisabetta Bolli; Alfonso Rosamilia; Simone Ottonello; Federica Cavallo; Gaetano Donofrio
Journal:  Oncoimmunology       Date:  2015-08-31       Impact factor: 8.110

9.  Induction of Antihuman C-C Chemokine Receptor Type 5 Antibodies by a Bovine Herpesvirus Type-4 Based Vector.

Authors:  Andrea Elizabeth Verna; Valentina Franceschi; Giulia Tebaldi; Francesca Macchi; Valentina Menozzi; Claudia Pastori; Lucia Lopalco; Simone Ottonello; Sandro Cavirani; Gaetano Donofrio
Journal:  Front Immunol       Date:  2017-10-25       Impact factor: 7.561

10.  Bovine Herpesvirus-4-Based Vector Delivering Peste des Petits Ruminants Virus Hemagglutinin ORF Induces both Neutralizing Antibodies and Cytotoxic T Cell Responses.

Authors:  Francesca Macchi; José Manuel Rojas; Andrea Elizabeth Verna; Noemí Sevilla; Valentina Franceschi; Giulia Tebaldi; Sandro Cavirani; Verónica Martín; Gaetano Donofrio
Journal:  Front Immunol       Date:  2018-03-05       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.